UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction

Nature communications, 2022-11, Vol.13 (1), p.6807-11, Article 6807

2022

Volltextzugriff (PDF)

Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2015-10, Vol.18 (4), p.740-750

2015

Volltextzugriff (PDF)

Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103+CD8+ T cells conferring favourable prognosis

British journal of cancer, 2020-05, Vol.122 (10), p.1525-1534

2020

Volltextzugriff (PDF)

Loss of RACK1 Promotes Metastasis of Gastric Cancer by Inducing a miR-302c/IL8 Signaling Loop

Cancer research (Chicago, Ill.), 2015-09, Vol.75 (18), p.3832-3841

2015

Volltextzugriff (PDF)

Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial

BMC medicine, 2022-04, Vol.20 (1), p.107-107, Article 107

2022

Volltextzugriff (PDF)

Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer

Journal of experimental & clinical cancer research, 2022-01, Vol.41 (1), p.14-14, Article 14

2022

Volltextzugriff (PDF)

Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy

Japanese journal of clinical oncology, 2016-01, Vol.46 (1), p.63-70

2016

Volltextzugriff (PDF)

Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA)

BMC cancer, 2023-04, Vol.23 (1), p.308-308, Article 308

2023

Volltextzugriff (PDF)

NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer

Frontiers in oncology, 2021-01, Vol.10, p.574937-574937

2021

Volltextzugriff (PDF)

Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer

Cancer Immunology, Immunotherapy, 2020-07, Vol.69 (7), p.1327-1336

2020

Volltextzugriff (PDF)

BAY 11-7082, a nuclear factor-κB inhibitor, induces apoptosis and S phase arrest in gastric cancer cells

Journal of gastroenterology, 2014-05, Vol.49 (5), p.864-874

2014

Volltextzugriff (PDF)

The role of oxaliplatin in the adjuvant setting of different Lauren’s type of gastric adenocarcinoma after D2 gastrectomy: a real-world study

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019-05, Vol.22 (3), p.587-597

2019

Volltextzugriff (PDF)

The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients

BMC cancer, 2015-10, Vol.15 (1), p.766-766, Article 766

2015

Volltextzugriff (PDF)

Snail is an independent prognostic predictor for progression and patient survival of gastric cancer

Cancer science, 2012-07, Vol.103 (7), p.1296-1303

2012

Volltextzugriff (PDF)

Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer

PloS one, 2013-08, Vol.8 (8), p.e71864-e71864

2013

Volltextzugriff (PDF)

The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III

BMC cancer, 2017-03, Vol.17 (1), p.238-238, Article 238

2017

Volltextzugriff (PDF)

PLOD3 contributes to HER-2 therapy resistance in gastric cancer through FoxO3/Survivin pathway

Cell death discovery, 2022-07, Vol.8 (1), p.321-321, Article 321

2022

Volltextzugriff (PDF)

Blockade of V‐domain immunoglobulin suppressor of T‐cell activation reprograms tumour‐associated macrophages and improves efficacy of PD‐1 inhibitor in gastric cancer

Clinical and translational medicine, 2024-02, Vol.14 (2), p.e1578-n/a

2024

Volltextzugriff (PDF)

C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer

Oncoimmunology, 2018-06, Vol.7 (6), p.e1433517-e1433517

2018

Volltextzugriff (PDF)

Prognostic value of stromal cell‐derived factor 1 expression in patients with gastric cancer after surgical resection

Cancer science, 2014-11, Vol.105 (11), p.1447-1456

2014

Volltextzugriff (PDF)

Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response

Oncoimmunology, 2020-01, Vol.9 (1), p.1856468-1856468

2020

Volltextzugriff (PDF)

Tumor size and perineural invasion predict outcome of gastric high-grade neuroendocrine neoplasms

Endocrine Connections, 2021-08, Vol.10 (8), p.947-954

2021

Volltextzugriff (PDF)

Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer

Annals of surgery, 2018-02, Vol.267 (2), p.311-318

2018

Volltextzugriff (PDF)

Expanded endoscopic therapy criteria should be cautiously used in intramucosal gastric cancer

Chinese journal of cancer research, 2016-06, Vol.28 (3), p.348-354

2016

Volltextzugriff (PDF)

Clinical and prognostic implications of β1, 6‐N‐acetylglucosaminyltransferase V in patients with gastric cancer

Cancer science, 2013-02, Vol.104 (2), p.185-193

2013

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(89)
Tagungsberichte
(6)

Sprache

Englisch
(93)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(6)
Bmc Cancer
(4)
Lupus
(4)
Cancer Science
(3)
Plos One
(3)
Tumor Biology
(3)
Annals Of Surgery
(2)
Archives Of Medical Science
(2)
Biochemical And Biophysical Research Communications
(2)
Gastric Cancer
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction

Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection

Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103+CD8+ T cells conferring favourable prognosis

Loss of RACK1 Promotes Metastasis of Gastric Cancer by Inducing a miR-302c/IL8 Signaling Loop

Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial

Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer

Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy

Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA)

NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer

Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer

BAY 11-7082, a nuclear factor-κB inhibitor, induces apoptosis and S phase arrest in gastric cancer cells

The role of oxaliplatin in the adjuvant setting of different Lauren’s type of gastric adenocarcinoma after D2 gastrectomy: a real-world study

The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients

Snail is an independent prognostic predictor for progression and patient survival of gastric cancer

Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer

The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III

PLOD3 contributes to HER-2 therapy resistance in gastric cancer through FoxO3/Survivin pathway

Blockade of V‐domain immunoglobulin suppressor of T‐cell activation reprograms tumour‐associated macrophages and improves efficacy of PD‐1 inhibitor in gastric cancer

C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer

Prognostic value of stromal cell‐derived factor 1 expression in patients with gastric cancer after surgical resection

Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response

Tumor size and perineural invasion predict outcome of gastric high-grade neuroendocrine neoplasms

Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer

Expanded endoscopic therapy criteria should be cautiously used in intramucosal gastric cancer

Clinical and prognostic implications of β1, 6‐N‐acetylglucosaminyltransferase V in patients with gastric cancer

Suchergebnisse filtern